CN113509426A - 一种具有修复妊娠纹和肥胖纹的植物提取复合物及其制备方法和应用 - Google Patents
一种具有修复妊娠纹和肥胖纹的植物提取复合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN113509426A CN113509426A CN202110816768.6A CN202110816768A CN113509426A CN 113509426 A CN113509426 A CN 113509426A CN 202110816768 A CN202110816768 A CN 202110816768A CN 113509426 A CN113509426 A CN 113509426A
- Authority
- CN
- China
- Prior art keywords
- parts
- striae
- repairing
- activated carbon
- adiposity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010040925 Skin striae Diseases 0.000 title claims abstract description 87
- 150000001875 compounds Chemical class 0.000 title claims abstract description 28
- 239000000419 plant extract Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 230000000694 effects Effects 0.000 claims abstract description 59
- 238000000605 extraction Methods 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 19
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 12
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 12
- 241001657422 Camellia petelotii Species 0.000 claims abstract description 12
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 12
- 241000218176 Corydalis Species 0.000 claims abstract description 12
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 12
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 12
- 244000173853 Sanguisorba officinalis Species 0.000 claims abstract description 12
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 12
- 241001071917 Lithospermum Species 0.000 claims abstract description 11
- 241000123835 Ampelopsis japonica Species 0.000 claims abstract description 10
- 244000146462 Centella asiatica Species 0.000 claims abstract description 9
- 235000004032 Centella asiatica Nutrition 0.000 claims abstract description 9
- 241000196324 Embryophyta Species 0.000 claims abstract description 9
- 244000038594 Phyllanthus urinaria Species 0.000 claims abstract description 9
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 7
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 claims abstract description 6
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 claims abstract description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000003814 drug Substances 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 108090000790 Enzymes Proteins 0.000 claims description 15
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 229940088598 enzyme Drugs 0.000 claims description 15
- 239000008213 purified water Substances 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- 208000031439 Striae Distensae Diseases 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 9
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 7
- 239000004365 Protease Substances 0.000 claims description 7
- 108010059892 Cellulase Proteins 0.000 claims description 6
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 6
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 6
- 235000017443 Hedysarum boreale Nutrition 0.000 claims description 6
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims description 6
- 108090000526 Papain Proteins 0.000 claims description 6
- 108010059820 Polygalacturonase Proteins 0.000 claims description 6
- 229940106157 cellulase Drugs 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 6
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 6
- 229940055729 papain Drugs 0.000 claims description 6
- 235000019834 papain Nutrition 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 244000061520 Angelica archangelica Species 0.000 claims description 5
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 5
- 239000008267 milk Substances 0.000 claims description 4
- 210000004080 milk Anatomy 0.000 claims description 4
- 235000013336 milk Nutrition 0.000 claims description 4
- 241000167550 Centella Species 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 230000005484 gravity Effects 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 230000004983 pleiotropic effect Effects 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000002023 wood Substances 0.000 claims description 2
- 244000235603 Acacia catechu Species 0.000 claims 3
- 208000008589 Obesity Diseases 0.000 abstract description 19
- 235000020824 obesity Nutrition 0.000 abstract description 19
- 230000037303 wrinkles Effects 0.000 abstract description 13
- 244000080767 Areca catechu Species 0.000 abstract description 9
- 230000037311 normal skin Effects 0.000 abstract description 6
- 208000024891 symptom Diseases 0.000 abstract description 5
- 239000002537 cosmetic Substances 0.000 abstract description 4
- 230000007794 irritation Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 238000005562 fading Methods 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 230000004089 microcirculation Effects 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 229910001385 heavy metal Inorganic materials 0.000 abstract description 2
- 239000005556 hormone Substances 0.000 abstract description 2
- 229940088597 hormone Drugs 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 230000037394 skin elasticity Effects 0.000 abstract description 2
- 230000009044 synergistic interaction Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 28
- 230000001737 promoting effect Effects 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 13
- 230000036407 pain Effects 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 230000008439 repair process Effects 0.000 description 9
- 206010042674 Swelling Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000035935 pregnancy Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 231100000241 scar Toxicity 0.000 description 5
- 240000001548 Camellia japonica Species 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- 208000032544 Cicatrix Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000018597 common camellia Nutrition 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000037387 scars Effects 0.000 description 3
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241001313857 Bletilla striata Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 244000181025 Rosa gallica Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000000222 aromatherapy Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- -1 polydimethylsiloxane Polymers 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- XXBAQTDVRLRXEV-UHFFFAOYSA-N 3-tetradecoxypropan-1-ol Chemical compound CCCCCCCCCCCCCCOCCCO XXBAQTDVRLRXEV-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000563984 Ampelopsis Species 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 241001083841 Aquatica Species 0.000 description 1
- 241000221377 Auricularia Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241001518935 Eragrostis Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 101000958041 Homo sapiens Musculin Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- LIJNLWJJUHXLIQ-UHFFFAOYSA-L disodium octanoate Chemical compound C(CCCCCCC)(=O)[O-].[Na+].[Na+].C(CCCCCCC)(=O)[O-] LIJNLWJJUHXLIQ-UHFFFAOYSA-L 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 102000046949 human MSC Human genes 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 229940051810 licorice root extract Drugs 0.000 description 1
- 235000020725 licorice root extract Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 210000000050 mohair Anatomy 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940116987 ppg-3 myristyl ether Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Biochemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于化妆品技术领域,公开了一种具有修复妊娠纹和肥胖纹的植物提取复合物及其制备方法和应用。所述植物提取复合物是由以下原料制成:白蔹、紫草、白及、儿茶、积雪草、当归、延胡索、三七、红花、珠丝毛蓝耳草、地榆、金花茶花、金花茶叶、甘草根。通过本发明各原料的有机结合,配方合理,很好地发挥了协同增效作用,共同达到抑菌抗炎,改善裂纹症状,淡化妊娠纹、肥胖纹或其它细纹,消除皱纹纸样外观,恢复皮肤正常颜色,改善微循环,提高皮肤弹性的功效。本发明产品安全有效,无刺激性、无激素、无重金属,让使用者避免有害物质的侵害。
Description
技术领域
本发明属于化妆品技术领域,特别涉及一种具有修复妊娠纹和肥胖纹的植物提取复合物及其制备方法和应用。
背景技术
肥胖纹和妊娠纹都属于膨胀纹,主要是体重增长过快或者怀孕,导致皮肤纤维层断裂,从而导致膨胀纹。肥胖纹和妊娠纹通常都是发生在腹部、臀部、大腿或者是腰底等部位。肥胖纹和妊娠纹一旦产生,难以自行消退,虽然对健康没有危害,但严重影响女性的体态和身心健康。目前常见的肥胖纹和妊娠纹祛除和淡化方法包括:(1)精油香薰法,该方法的疗程较长,对香薰操作有一定的技术要求,效果也难以达到理想的程度;(2)换肤法,通过物理或化学的方法进行换肤,该方法虽然见效快,但创伤较大,敏感肤质容易导致新的瘢痕,且使用化学脱皮剂等容易引起不良反应;(3)激光疗法,该方法不适合大面积治疗,对激光操作的技术要求高,成本较高,不易掌握深浅,常留有疤痕,治疗效果也不够理想;(4)磨削法,大面积治疗会给患者带来痛苦且留有疤痕,不适合用于妊娠纹治疗;(5)霜膏按摩法,该方法通过使用修复护肤品结合按摩来促进活性成分的吸收和皮肤的修复,操作较方便,无副作用,容易被消费者所接受,但修复化妆品质量参差不齐,部分修复化妆品只能起到常规的保湿和滋润效果。
因此,提供一种安全有效、防治效果稳定且成本较低的修复妊娠纹和肥胖纹的护肤品将迎合广大消费者的需求,具有广阔的市场前景。
发明内容
为了克服现有技术中存在的缺点和不足,本发明的首要目的在于提供一种具有修复妊娠纹和肥胖纹的植物提取复合物。
本发明的另一目的在于提供一种上述具有修复妊娠纹和肥胖纹的植物提取复合物的制备方法。
本发明的再一目的在于提供一种上述具有修复妊娠纹和肥胖纹的植物提取复合物的应用。
本发明的目的通过下述技术方案实现:
一种具有修复妊娠纹和肥胖纹的植物提取复合物,所述植物提取复合物是由以下原料制成:白蔹、紫草、白及、儿茶、积雪草、当归、延胡索、三七、红花、珠丝毛蓝耳草、地榆、金花茶花、金花茶叶和甘草根。
优选地,该植物提取复合物是由以下按重量份数计的原料制成:白蔹80-100份、紫草50-70份、白及80-100份、儿茶30-40份、积雪草50-70份、当归25-30份、延胡索30-40份、三七30-40份、红花30-40份、珠丝毛蓝耳草50-70份、地榆30-40份、金花茶花30-40份、金花茶叶30-40份和甘草根20-30份。
更加优选地,该植物提取复合物是由以下按重量份数计的原料制成:白蔹90份、紫草60份、白及90份、儿茶30份、积雪草60份、当归25份、延胡索30份、三七305份、红花35份、珠丝毛蓝耳草60份、地榆40份、金花茶花35份、金花茶叶35份和甘草根20份。
上述具有修复妊娠纹和肥胖纹的植物提取复合物的制备方法,包括以下操作步骤:
(1)将所有原料清洗干净之后进行粉碎至十目粗粉,得到中药粗粉;
(2)将中药粗粉投入多功能提取罐中,加入中药粗粉8倍重量的乙醇溶液,乙醇溶液的体积百分比浓度为95%,浸泡48小时后,升温至60℃,开启多功能提取罐强制循环1小时,保温4小时;将所得提取液过滤,获得醇提液;
(3)向步骤(2)醇提后的滤渣中加入纯化水、木瓜蛋白酶、纤维素酶和果胶酶,调整pH值为5.5;浸泡6小时后升温至55℃,强制循环1小时,恒温180min;将所得提取液过滤,获得酶提液;纯化水的添加量为50倍滤渣重量;木瓜蛋白酶添加量为滤渣和纯化水总质量的0.4%,酶活力要求10万u/g;纤维素酶添加量为滤渣和纯化水总质量的0.08%,酶活力要求40万u/g;果胶酶添加量为滤渣和纯化水总质量的0.15%,酶活力要求5万u/g;
(4)将步骤(2)所得醇提液和步骤(3)所得酶提液混合,减压浓缩至液体比重为1.10的浸膏;
(5)浸膏打入萃取罐中,再加入药用活性碳,浸膏和药用活性碳的重量比为7:1,搅拌升温至55℃,3小时后过滤;多次过滤至滤液清晰透明,无明显药味为止;
(6)清洁、消毒、包装,得到具有修复妊娠纹和肥胖纹的植物提取复合物。
步骤(5)所述药用活性碳为767型针剂活性炭、769型针剂活性炭、303型木质活性炭和ACTICAR80NE活性炭的混合物。
上述的一种具有修复妊娠纹和肥胖纹的植物提取复合物在制备妊娠纹和肥胖纹修复多效乳中的应用。
本发明的原理:
白蔹的功效作用:清热解毒,消痈散结,敛疮生肌,用于痈疸发背,疔疮瘰疬,烧烫伤;用于皮肤可以祛除粉刺、冻疮,美白淡斑的功效。
紫草的功效作用:具有解毒透疹、凉血活血的功效,临床主要用于温热病、小儿发疹性疾病,比如小儿麻疹,风疹,猩红热等以及湿疹和外阴瘙痒等皮肤病;在护肤品中可以作为抗炎剂、抗氧剂,提取物对组织蛋白酶活性有促进作用,表示其可增强皮肤细胞新陈代谢。
白及的功效作用:收敛止血,消肿生肌,用于咯血、吐血,外伤出血,疮疡肿毒,皮肤皲裂;带有丰富的挥发油和粘液质,具有祛斑美白功效,能清除皮肤留有的印痕、滋养美白皮肤。
儿茶的功效作用:具有活血止痛,止血生肌,收湿敛疮,清肺化痰的功效。用于跌扑伤痛,外伤出血,吐血衄血,疮疡不敛,湿疹、湿疮,肺热咳嗽。
积雪草的功效作用:主要治疗发热、咳喘、咽喉肿痛、肠炎、痢疾、湿热黄疸、水肿、淋证、尿血、痛经、崩漏、丹毒、瘰疬、疔疮肿毒、带状疱疹、跌打肿痛、外伤出血、蛇虫咬伤等疾病,都能够很好的治疗。积雪草提取物积雪草苷对瘢痕成纤维细胞活力促进作用,能促进疤痕修复。
当归的功效作用:治疗心肝血虚引起的面色发白、指甲无色、头昏目眩、心悸怔忡。具有补气和血,调经止痛,润燥滑肠、抗癌、抗老防老免疫之功效;用于皮肤可以促进血液循环,具有极强的抑制硌氨酸酶活性作用,利于祛斑嫩肤。
延胡索的功效作用:具有止痛、活血利气的功效。临床中常用于胃痛、腹痛、胁痛、疝气痛和痛经、分娩痛、腰痛、肢体痛、头痛等多种疼痛,但多用于气血阻滞所导致的疼痛。
三七的功效作用:散瘀止血,消肿定痛。用于咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹刺痛,跌扑肿痛,用于皮肤可以消除和减少皮肤皱纹及老年斑等功效。
红花的功效作用:活血通经,散瘀止痛。用于:经闭,痛经,恶露不行,癜瘕痞块,跌扑损伤,疮疡肿痛;用于皮肤可以祛除属血瘀者黄褐斑。
珠丝毛蓝耳草的功效作用:祛风活络,利湿消肿,外用治湿疹,脚癣,刀伤;酒精提取物浓度0.1%露水草β-蜕皮激素及2-乙酰氧基-β-蜕皮激素对皮肤新陈代谢活化率为111%和112%;说明其具有再生皮肤,促进皮肤新陈代谢作用。
地榆的功效作用:凉血、止血、清热解毒、培清养阴、消肿敛疮,可用于湿疹。
金花茶花的功效作用:富含多种氨基酸和微量元素、总黄酮、总皂甙,能滋润营养肌肤,提高肌肤修护力。
金花茶叶的功效作用:清热解毒,利尿消肿;外用可治疗疮疡。
甘草根的功效作用:缓解药物毒性、烈性,调和诸药。甘草根提取物对肌肤细胞、血管内皮细胞增殖以及胶原蛋白-4型生成有促进作用,是很好的抗衰剂。
本发明相对于现有技术具有如下的优点及效果:
(1)本发明白蔹和白及在方中共为君药,发挥主要治疗作用,淡化妊娠纹、肥胖纹颜色,消除皱纹;紫草、积雪草和珠丝毛蓝耳草在方中为臣药,协助君药发挥作用;儿茶、当归、延胡索、三七、红花、地榆、金花茶花和金花茶叶在方中为佐药,用于辅助君臣药治疗主症并且治疗兼症;甘草根在方中为使药,引导药物直达病所。通过本发明各原料的有机结合,配方合理,很好地发挥了协同增效作用,共同达到抑菌抗炎,改善裂纹症状,淡化妊娠纹、肥胖纹或其它细纹,消除皱纹纸样外观,恢复皮肤正常颜色,改善微循环,提高皮肤弹性的功效。
(2)本发明产品安全有效,无刺激性、无激素、无重金属,让使用者避免有害物质的侵害。
具体实施方式
下面结合实施例对本发明作进一步详细的描述,但本发明的实施方式不限于此。
以下对比例和实施例所述植物提取复合物的制备方法,具体包括以下操作步骤:
(1)将所有原料清洗干净之后进行粉碎至十目粗粉,得到中药粗粉;
(2)将中药粗粉投入多功能提取罐中,加入中药粗粉8倍重量的乙醇溶液,乙醇溶液的体积百分比浓度为95%,浸泡48小时后,升温至60℃,开启多功能提取罐强制循环1小时,保温4小时;将所得提取液过滤,获得醇提液;
(3)向步骤(2)醇提后的滤渣中加入纯化水、木瓜蛋白酶、纤维素酶和果胶酶,调整pH值为5.5;浸泡6小时后升温至55℃,强制循环1小时,恒温180min;将所得提取液过滤,获得酶提液;纯化水的添加量为50倍滤渣重量;木瓜蛋白酶添加量为滤渣和纯化水总质量的0.4%,酶活力要求10万u/g;纤维素酶添加量为滤渣和纯化水总质量的0.08%,酶活力要求40万u/g;果胶酶添加量为滤渣和纯化水总质量的0.15%,酶活力要求5万u/g;
(4)将步骤(2)所得醇提液和步骤(3)所得酶提液混合,减压浓缩至液体比重为1.10的浸膏;
(5)浸膏打入萃取罐中,再加入药用活性碳,浸膏和药用活性碳的重量比为7∶1,搅拌升温至55℃,3小时后过滤;多次过滤至滤液清晰透明,无明显药味为止;
(6)清洁、消毒、包装,得到具有修复妊娠纹和肥胖纹的植物提取复合物。
对比例1
一种植物提取复合物,该植物提取复合物是由以下按重量份数计的原料制成:紫草60份、儿茶30份、积雪草60份、当归25份、延胡索30份、三七305份、红花35份、珠丝毛蓝耳草60份、地榆40份、金花茶花35份、金花茶叶35份和甘草根20份。
对比例2
一种植物提取复合物,该植物提取复合物是由以下按重量份数计的原料制成:白蔹90份、白及90份、儿茶30份、积雪草60份、当归25份、延胡索30份、三七305份、红花35份、地榆40份、金花茶花35份、金花茶叶35份和甘草根20份。
实施例1:
一种具有修复妊娠纹和肥胖纹的植物提取复合物,该植物提取复合物是由以下按重量份数计的原料制成:白蔹90份、紫草60份、白及90份、儿茶30份、积雪草60份、当归25份、延胡索30份、三七305份、红花35份、珠丝毛蓝耳草60份、地榆40份、金花茶花35份、金花茶叶35份和甘草根20份。
实施例2:安全性试验
1、将三组家兔(每组5只,共15只)背部减去部分毛,露出皮肤,在皮肤裸露部分分别涂抹实施例1和对比例1、2的植物提取复合物,涂抹一小时后观察结果,与未涂抹区域相比,均没有出现红斑或水肿,表明没有刺激性和过敏反应。按照上述操作,连续观察15天,结果一致。
2、采用实施例1和对比例1、2的植物提取复合物涂抹在三组志愿受试者(每组20人,共60人)的手部皮肤,在0-24h内每隔3小时观察一次,均未出现发红、发疹和起泡现象,未发现不良反应。
试验证明本发明提供的植物提取复合物无刺激性,具有高度安全性。
实施例3:肥胖纹修复效果
选取90名年龄在25-65岁的有肥胖纹的男性志愿受试者,随机分成3组,每组30人,分别使用实施例1和对比例1、2的植物提取复合物涂抹在有肥胖纹的皮肤处,一日2次,早晚各一次,轻轻按摩至吸收,连续涂抹30日,观察使用效果,结果如表1所示。效果评价按照以下:
显效:肥胖纹色泽变浅,皱纹消失,与正常皮肤无明显差别;
有效:肥胖纹色泽稍变浅,皱纹几乎消失,与正常皮肤分界模糊;
无效:肥胖纹色泽和皱纹均无变化。
表1植物提取复合物对肥胖纹修复效果
试验组 | 实施例1 | 对比例1 | 对比例2 |
显效/人 | 28 | 20 | 22 |
有效/人 | 2 | 6 | 5 |
无效/人 | 0 | 4 | 3 |
从表1可以看出,与对照组相比,差异显著,说明本发明植物提取复合物能明显淡化肥胖纹,消除皱纹纸样外观,具有很好的修复肥胖纹的效果。本发明原料配方合理,各组分之间起着协同增效的作用,相对删减了个别原料组分的对比例1和2,还是本发明提供的植物提取复合物能极大程度地改观肥胖纹皮肤,说明本发明配方中各组分之间存在协同作用。
实施例4:妊娠纹修复效果
选取90名年龄在25-45岁的有妊娠纹的女性志愿受试者,随机分成3组,每组30人,分别使用实施例1和对比例1、2的植物提取复合物涂抹在有妊娠纹的皮肤处,一日2次,早晚各一次,,轻轻按摩至吸收,连续涂抹30日观察使用效果,结果如表1所示。效果评价按照以下:
显效:妊娠纹色泽变浅,皱纹消失,与正常皮肤无明显差别;
有效:妊娠纹色泽稍变浅,皱纹几乎消失,与正常皮肤分界模糊;
无效:妊娠纹色泽和皱纹均无变化。
表1植物提取复合物对妊娠纹修复效果
试验组 | 实施例1 | 对比例1 | 对比例2 |
显效/人 | 29 | 22 | 21 |
有效/人 | 1 | 4 | 6 |
无效/人 | 0 | 4 | 3 |
从表1可以看出,与对照组相比,差异显著,说明本发明植物提取复合物能明显淡化妊娠纹,消除皱纹纸样外观,具有很好的修复妊娠纹效果。本发明原料配方合理,各组分之间起着协同增效的作用,相对删减了个别原料组分的对比例1和2,还是本发明提供的植物提取复合物能极大程度地改观妊娠纹皮肤,说明本发明配方中各组分之间存在协同作用。
实施例5:
将实施例1所得植物提取复合物制备成妊娠纹和肥胖纹修复多效乳,该多效乳是由以下按重量百分比计的组分组成:65-80%植物提取复合物、5-10%丁二醇、0.01-0.4%甘油聚醚-26、0.02-0.2%异硬脂醇异硬脂酸酯、0.1-0.2%二(PPG-3肉豆蔻基醚)己二酸酯、0.01-0.03%异十六烷、0.05-0.1%聚山梨醇酯-60、0.01-0.02%聚二甲基硅氧烷、0.05-0.08%鲸蜡硬脂醇、0.06-0.09%甘油硬脂酸酯、0.01-0.3%聚丙烯酸钠、5-10%丙二醇、0.01-0.05%矿油、0.01-0.05%山茶(CAMELLIA JAPONICA)花提取物、0.01-0.05%黄原胶、0.01-0.05%乙醇、0.01-0.3%聚山梨醇酯-80、0.01-0.5%EDTA二钠、0.05-0.2%辛酰羟肟酸、0.05-0.08%甘油辛酸酯、0.03-0.06%柠檬酸、0.01-0.4%氢氧化钠、0.01-0.2%山梨(糖)醇、0.01-0.02%乙基己基甘油、0.01-0.06%透明质酸、0.1-0.2%聚二甲基硅氧烷交联聚合物、0.5-0.8%甘油、0.05-0.08%羟基硬脂酸乙基己酯、0.8-1%突厥蔷薇(ROSADAMASCENA)花油、0.01-0.5%癸基葡糖苷、余量为水。
通过30名年龄在25-45岁的、有肥胖纹或者妊娠纹的志愿者使用上述妊娠纹和肥胖纹修复多效乳的实践效果来看,该妊娠纹和肥胖纹修复多效乳对妊娠纹和肥胖纹都有非常好的修复作用,改善裂纹症状,淡化妊娠纹或肥胖纹,消除皱纹纸样外观,恢复皮肤正常颜色,改善微循环,提高皮肤弹性的功效。同时通过20名年龄在25-45岁的女性志愿者在面部使用上述妊娠纹和肥胖纹修复多效乳的实践效果来看,该妊娠纹和肥胖纹修复多效乳还可以改善和修复面部细纹,脸色变红润、弹性有光泽。
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。
Claims (6)
1.一种具有修复妊娠纹和肥胖纹的植物提取复合物,其特征在于:所述植物提取复合物是由以下原料制成:白蔹、紫草、白及、儿茶、积雪草、当归、延胡索、三七、红花、珠丝毛蓝耳草、地榆、金花茶花、金花茶叶和甘草根。
2.根据权利要求1所述的一种具有修复妊娠纹和肥胖纹的植物提取复合物,其特征在于:该植物提取复合物是由以下按重量份数计的原料制成:白蔹80-100份、紫草50-70份、白及80-100份、儿茶30-40份、积雪草50-70份、当归25-30份、延胡索30-40份、三七30-40份、红花30-40份、珠丝毛蓝耳草50-70份、地榆30-40份、金花茶花30-40份、金花茶叶30-40份和甘草根20-30份。
3.根据权利要求1所述的一种具有修复妊娠纹和肥胖纹的植物提取复合物,其特征在于:该植物提取复合物是由以下按重量份数计的原料制成:白蔹90份、紫草60份、白及90份、儿茶30份、积雪草60份、当归25份、延胡索30份、三七305份、红花35份、珠丝毛蓝耳草60份、地榆40份、金花茶花35份、金花茶叶35份和甘草根20份。
4.根据权利要求1所述的一种具有修复妊娠纹和肥胖纹的植物提取复合物的制备方法,其特征在于包括以下操作步骤:
(1)将所有原料清洗干净之后进行粉碎至十目粗粉,得到中药粗粉;
(2)将中药粗粉投入多功能提取罐中,加入中药粗粉8倍重量的乙醇溶液,乙醇溶液的体积百分比浓度为95%,浸泡48小时后,升温至60℃,开启多功能提取罐强制循环1小时,保温4小时;将所得提取液过滤,获得醇提液;
(3)向步骤(2)醇提后的滤渣中加入纯化水、木瓜蛋白酶、纤维素酶和果胶酶,调整pH值为5.5;浸泡6小时后升温至55℃,强制循环1小时,恒温180min;将所得提取液过滤,获得酶提液;纯化水的添加量为50倍滤渣重量;木瓜蛋白酶添加量为滤渣和纯化水总质量的0.4%,酶活力要求10万u/g;纤维素酶添加量为滤渣和纯化水总质量的0.08%,酶活力要求40万u/g;果胶酶添加量为滤渣和纯化水总质量的0.15%,酶活力要求5万u/g;
(4)将步骤(2)所得醇提液和步骤(3)所得酶提液混合,减压浓缩至液体比重为1.10的浸膏;
(5)浸膏打入萃取罐中,再加入药用活性碳,浸膏和药用活性碳的重量比为7∶1,搅拌升温至55℃,3小时后过滤;多次过滤至滤液清晰透明,无明显药味为止;
(6)清洁、消毒、包装,得到具有修复妊娠纹和肥胖纹的植物提取复合物。
5.根据权利要求4所述的制备方法,其特征在于:步骤(5)所述药用活性碳为767型针剂活性炭、769型针剂活性炭、303型木质活性炭和ACTICAR80NE活性炭的混合物。
6.根据权利要求1所述的一种具有修复妊娠纹和肥胖纹的植物提取复合物在制备妊娠纹和肥胖纹修复多效乳中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110816768.6A CN113509426A (zh) | 2021-07-19 | 2021-07-19 | 一种具有修复妊娠纹和肥胖纹的植物提取复合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110816768.6A CN113509426A (zh) | 2021-07-19 | 2021-07-19 | 一种具有修复妊娠纹和肥胖纹的植物提取复合物及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113509426A true CN113509426A (zh) | 2021-10-19 |
Family
ID=78067375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110816768.6A Pending CN113509426A (zh) | 2021-07-19 | 2021-07-19 | 一种具有修复妊娠纹和肥胖纹的植物提取复合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113509426A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113384642A (zh) * | 2021-07-15 | 2021-09-14 | 忧立舒医药科技(广东)有限公司 | 一种具有祛痘功效的天然提取复合物及其制备方法和应用 |
CN113940965A (zh) * | 2021-10-11 | 2022-01-18 | 荐康(广州)生物技术有限公司 | 一种淡化、消除妊娠纹的外用药物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112656872A (zh) * | 2021-01-26 | 2021-04-16 | 忧立舒医药科技(广东)有限公司 | 一种植物止脱生发液及其制备方法和应用 |
-
2021
- 2021-07-19 CN CN202110816768.6A patent/CN113509426A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112656872A (zh) * | 2021-01-26 | 2021-04-16 | 忧立舒医药科技(广东)有限公司 | 一种植物止脱生发液及其制备方法和应用 |
Non-Patent Citations (1)
Title |
---|
国产非特殊用途化妆品备案信息服务平台: "忧立舒植萃多效焕肤乳", 《FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=20210424144811UHZ9C&NID=20210424144811UHZ9C》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113384642A (zh) * | 2021-07-15 | 2021-09-14 | 忧立舒医药科技(广东)有限公司 | 一种具有祛痘功效的天然提取复合物及其制备方法和应用 |
CN113940965A (zh) * | 2021-10-11 | 2022-01-18 | 荐康(广州)生物技术有限公司 | 一种淡化、消除妊娠纹的外用药物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105213284A (zh) | 一种祛痘保湿霜及其制备方法 | |
CN106137823A (zh) | 一种美白祛斑组合物及其应用 | |
CN106728457B (zh) | 一种中药祛痘面膜 | |
CN113384642A (zh) | 一种具有祛痘功效的天然提取复合物及其制备方法和应用 | |
CN113018238A (zh) | 一种抑菌消炎清爽益肤的祛痘凝胶及其制备方法 | |
CN113509426A (zh) | 一种具有修复妊娠纹和肥胖纹的植物提取复合物及其制备方法和应用 | |
CN101653409B (zh) | 一种美白祛斑霜及其制备方法 | |
CN104323961A (zh) | 一种美白祛斑中药面膜及其制备方法 | |
CN114146014B (zh) | 一种复方烟酸薄荷酯植物多糖乳膏及其制备方法 | |
CN106511211B (zh) | 一种抗炎祛痘护肤乳液及其制备方法 | |
CN106580838A (zh) | 一种中药美白淡斑精华及其制备方法 | |
CN105125467A (zh) | 一种祛红血丝乳液及其制备方法 | |
CN110339249B (zh) | 一种用于痔疮肛裂的中药组合物及其制备方法和应用 | |
CN106890120A (zh) | 一种中药美白淡斑乳及其制备方法 | |
CN106924134A (zh) | 一种中药美白淡斑霜及其制备方法 | |
CN105213285A (zh) | 一种祛痘洗面奶及其制备方法 | |
CN114469845B (zh) | 一种利用大胡蜂蜂针液的外用制剂及其制备方法 | |
CN114306410A (zh) | 一种紫草膏及其制备方法与应用 | |
CN109431824B (zh) | 一种抗菌除臭凝胶及其应用 | |
CN110934785A (zh) | 一种美白保湿敏感肌肤用洗面奶及其制备方法 | |
CN102626471B (zh) | 一种具有防敏脱敏、修复再生作用的中药组合物 | |
CN108785191A (zh) | 纯中药净白祛斑面霜 | |
CN108403603A (zh) | 一种樱桃山柰美容祛斑天然中药面膜膏及其制备方法 | |
CN109010187A (zh) | 一种用于治疗痤疮的面霜及其制备方法 | |
CN116747267B (zh) | 一种生发中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211019 |